Venus Remedies

77
Buy
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE411B01019
  • NSEID: VENUSREM
  • BSEID: 526953
INR
759.00
6.1 (0.81%)
BSENSE

Dec 05

BSE+NSE Vol: 50.79 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Venus Remedies Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
44.00
37.00
36.00
25.00
0.00
-29.00
Adjustment
20.00
23.00
26.00
21.00
41.00
60.00
Changes In working Capital
-12.00
-24.00
-21.00
61.00
20.00
14.00
Cash Flow after changes in Working Capital
52.00
36.00
41.00
108.00
63.00
45.00
Cash Flow from Operating Activities
37.00
36.00
41.00
131.00
77.00
45.00
Cash Flow from Investing Activities
-8.00
-58.00
-17.00
57.00
-4.00
-11.00
Cash Flow from Financing Activities
-1.00
0.00
-9.00
-162.00
-73.00
-35.00
Net Cash Inflow / Outflow
27.00
-22.00
14.00
26.00
0.00
-1.00
Opening Cash & Cash Equivalents
21.00
43.00
28.00
1.00
2.00
3.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
48.00
21.00
43.00
28.00
1.00
2.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Venus Remedies
Markets Mojo
Figures in Cr
standaloned Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
46.65
42
4.00
11.07%
Adjustment
19.36
46.42
-27.00
-58.29%
Changes In working Capital
-15.15
-62.21
47.00
75.65%
Cash Flow after changes in Working Capital
50.87
26.21
24.00
94.09%
Cash Flow from Operating Activities
35.38
21.62
14.00
63.64%
Cash Flow from Investing Activities
-6.94
-14.82
8.00
53.17%
Cash Flow from Financing Activities
0
-6.38
6.00
100.00%
Net Cash Inflow / Outflow
28.44
0.43
28.00
6513.95%
Opening Cash & Cash Equivalents
20.07
2.17
18.00
824.88%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
48.51
2.6
46.00
1765.77%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is 1.80% vs -10.88% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
37.29
36.63
1.80%